Thoratec Stock Price, News & Analysis (NASDAQ:THOR)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Thoratec (NASDAQ:THOR)

Thoratec logoThoratec Corporation develops, manufactures and markets medical devices used for mechanical circulatory support for the treatment of heart failure patients. The Company's products include ventricular assist devices (VADs), such as HeartMate II Left Ventricular Assist System (HeartMate II), HeartMate III Left Ventricular Assist System, Thoratec Paracorporeal Ventricular Assist Device (PVAD) and Thoratec Implantable Ventricular Assist Device (IVAD). For acute circulatory support, the Company's product lines are CentriMag Acute Circulatory System (CentriMag) and for pediatric patients PediMag/PediVAS Acute Circulatory System (PediMag/PediVAS). HeartMate III, a centrifugal-flow, chronic, left ventricular assist system.

Receive THOR News and Ratings via Email

Sign-up to receive the latest news and ratings for THOR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryHealth Care Equipment
SectorHealthcare
SymbolNASDAQ:THOR
CUSIP88517530
Phone+1-925-8478600

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS$0.70
Net IncomeN/A
Net Margins10.29%
Return on Equity8.02%
Return on Assets6.71%

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Thoratec (NASDAQ:THOR) Frequently Asked Questions

What is Thoratec's stock symbol?

Thoratec trades on the NASDAQ under the ticker symbol "THOR."

How were Thoratec's earnings last quarter?

Thoratec Co. (NASDAQ:THOR) released its quarterly earnings data on Tuesday, August, 4th. The medical instruments supplier reported $0.37 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.28 by $0.09. The medical instruments supplier had revenue of $128.70 million for the quarter, compared to the consensus estimate of $115.48 million. Thoratec had a net margin of 10.29% and a return on equity of 8.02%. The company's revenue was up 9.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.43 earnings per share. View Thoratec's Earnings History.

Who are some of Thoratec's key competitors?

How do I buy Thoratec stock?

Shares of Thoratec can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Thoratec?

Thoratec's mailing address is 6035 Stoneridge Dr, PLEASANTON, CA 94588, United States. The medical instruments supplier can be reached via phone at +1-925-8478600.


MarketBeat Community Rating for Thoratec (THOR)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  257 (Vote Outperform)
Underperform Votes:  270 (Vote Underperform)
Total Votes:  527
MarketBeat's community ratings are surveys of what our community members think about Thoratec and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Thoratec (NASDAQ:THOR) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Thoratec (NASDAQ:THOR) Earnings History and Estimates Chart

Earnings by Quarter for Thoratec (NASDAQ:THOR)

Thoratec (NASDAQ THOR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2015Q215$0.28$0.37$115.48 million$128.70 millionViewListenView Earnings Details
5/7/2015Q115$0.26$0.38$111.10 million$121.31 millionViewListenView Earnings Details
2/10/2015Q414$0.24$0.39$106.90 million$127.96 millionViewListenView Earnings Details
11/5/2014Q314$0.22$0.18$106.30 million$105.80 millionViewListenView Earnings Details
8/6/2014Q214$0.43$0.43$128.30 million$118.10 millionViewListenView Earnings Details
5/6/2014Q114$0.39$0.41$122.56 million$125.70 millionViewListenView Earnings Details
2/4/2014Q413$0.41$0.38$128.47 million$128.20 millionViewListenView Earnings Details
10/30/2013Q313$0.40$0.49$121.25 million$126.40 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.43$0.52$121.51 million$130.50 millionViewListenView Earnings Details
5/2/2013Q1 2013$0.46$0.41$122.53 million$117.73 millionViewListenView Earnings Details
2/5/2013Q4 2012$0.38$0.38$119.09 million$128.50 millionViewListenView Earnings Details
11/1/2012Q312$0.39$0.41$111.80 million$117.80 millionViewN/AView Earnings Details
8/1/2012$0.45$0.45ViewN/AView Earnings Details
5/1/2012$0.41$0.61ViewN/AView Earnings Details
11/1/2011$0.33$0.41ViewN/AView Earnings Details
8/3/2011$0.35$0.44ViewN/AView Earnings Details
5/3/2011$0.33$0.34ViewN/AView Earnings Details
1/27/2011$0.30$0.28ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Thoratec (NASDAQ:THOR) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Thoratec (NASDAQ:THOR)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Thoratec (NASDAQ THOR) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Thoratec (NASDAQ:THOR)

Thoratec (NASDAQ THOR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2015Neil F DimickDirectorSell8,173$44.98$367,621.54View SEC Filing  
5/15/2015Paul A LavioletteDirectorSell5,668$44.70$253,359.60View SEC Filing  
4/10/2015Neil F DimickDirectorSell4,786$43.00$205,798.00View SEC Filing  
12/4/2014J Daniel ColeDirectorSell5,000$31.83$159,150.00View SEC Filing  
5/27/2014Neil F DimickDirectorSell4,158$32.15$133,679.70View SEC Filing  
5/15/2014Paul LavioletteDirectorSell6,023$31.23$188,098.29View SEC Filing  
3/10/2014Gerhard BurbachCEOSell22,104$36.53$807,459.12View SEC Filing  
2/11/2014Gerhard BurbachCEOSell20,000$34.71$694,200.00View SEC Filing  
1/15/2014Gerhard BurbachCEOSell9,400$38.10$358,140.00View SEC Filing  
1/14/2014Gerhard BurbachCEOSell30,600$36.65$1,121,490.00View SEC Filing  
12/10/2013Gerhard BurbachCEOSell40,000$38.15$1,526,000.00View SEC Filing  
11/12/2013Gerhard BurbachCEOSell100,000$41.40$4,140,000.00View SEC Filing  
10/28/2013Gerhard F BurbachCEOSell15,000$40.02$600,300.00View SEC Filing  
10/17/2013Gerhard F BurbachCEOSell9,600$39.00$374,400.00View SEC Filing  
10/14/2013Gerhard BurbachCEOSell40,400$38.17$1,542,068.00View SEC Filing  
10/11/2013David Aaron LehmanSVPSell21,889$38.17$835,503.13View SEC Filing  
5/28/2013Neil F DimickDirectorSell1,273$31.58$40,201.34View SEC Filing  
5/20/2013Neil F DimickDirectorSell1,250$31.61$39,512.50View SEC Filing  
5/13/2013Neil F DimickDirectorSell1,250$33.93$42,412.50View SEC Filing  
11/26/2012Gerhard F BurbachCEOSell11,600$38.09$441,844.00View SEC Filing  
10/4/2012David Aaron LehmanSVPSell12,300$36.11$444,153.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Thoratec (NASDAQ THOR) News Headlines

Source:
DateHeadline
Analyzing Thoratec (THOR) & Waters (WAT)Analyzing Thoratec (THOR) & Waters (WAT)
www.americanbankingnews.com - December 11 at 9:30 PM
Top Funds' New Buys: GrubHub Delivers Food, ProfitTop Funds' New Buys: GrubHub Delivers Food, Profit
finance.yahoo.com - December 5 at 10:31 AM
Critical Contrast: Thoratec (THOR) & Waters (WAT)Critical Contrast: Thoratec (THOR) & Waters (WAT)
www.americanbankingnews.com - December 1 at 5:40 AM
EnteroMedics (ETRM) & Thoratec (THOR) Head-To-Head ReviewEnteroMedics (ETRM) & Thoratec (THOR) Head-To-Head Review
www.americanbankingnews.com - October 11 at 12:08 AM
Thoratec (THOR) & Biolase (BIOL) Critical AnalysisThoratec (THOR) & Biolase (BIOL) Critical Analysis
www.americanbankingnews.com - October 5 at 9:46 AM
Dont Buy RV Stocks As Hurricane PlaysDon't Buy RV Stocks As Hurricane Plays
finance.yahoo.com - September 7 at 9:54 AM
Reviewing Thoratec (THOR) & Intuitive Surgical (ISRG)Reviewing Thoratec (THOR) & Intuitive Surgical (ISRG)
www.americanbankingnews.com - August 20 at 2:28 PM
Head-To-Head Comparison: Accuray (ARAY) & Thoratec (NASDAQ:THOR)Head-To-Head Comparison: Accuray (ARAY) & Thoratec (NASDAQ:THOR)
www.americanbankingnews.com - July 4 at 8:25 AM
Thor Industries Stock Drops Double Digits on Mixed EarningsThor Industries Stock Drops Double Digits on Mixed Earnings
www.thestreet.com - March 7 at 8:04 PM
Sunshine Heart Appoints Steve Brandt and Matthew E. Likens to Board of DirectorsSunshine Heart Appoints Steve Brandt and Matthew E. Likens to Board of Directors
feeds.benzinga.com - February 3 at 6:39 AM
Global Congestive Heart Failure (CHF) Treatment Devices Market Analysis & Trends - Industry Forecast to 2025 - Research and MarketsGlobal Congestive Heart Failure (CHF) Treatment Devices Market Analysis & Trends - Industry Forecast to 2025 - Research and Markets
www.bizjournals.com - January 28 at 6:56 AM
How Big Is the St. Jude Medical Threat to Abiomed, Inc. Stock?How Big Is the St. Jude Medical Threat to Abiomed, Inc. Stock?
www.fool.com - January 4 at 6:31 AM
Winnebago Shares Surge 22% On Grand Design Acquisition, Baird UpgradeWinnebago Shares Surge 22% On Grand Design Acquisition, Baird Upgrade
blogs.barrons.com - October 3 at 7:07 PM
Global Artificial Organs Industry - Annual estimates and forecasts 2015 - 2022Global Artificial Organs Industry - Annual estimates and forecasts 2015 - 2022
www.prnewswire.com - September 26 at 7:40 PM

SEC Filings

Thoratec (NASDAQ:THOR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Thoratec (NASDAQ:THOR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Thoratec (NASDAQ THOR) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.